Influence of SPECT attenuation correction on the quantification of hibernating myocardium as derived from combined myocardial perfusion SPECT and 18F-FDG PET

Journal of Nuclear Cardiology

Volumn 21, Issue 3, 2014, Pages 578-587

  Lehner, Sebastian ^a   Sussebach, Christian ^a   Todica, Andrei ^a   Uebleis, Christopher ^a   Brunner, Stefan ^a   Bartenstein, Peter ^a   Van Kriekinge, Serge D ^b   Germano, Guido ^b   Hacker, Marcus ^c  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

attenuation correction; FDG; hibernating myocardium; Myocardial perfusion scintigraphy; viability

Indexed keywords

FLUORODEOXYGLUCOSE F 18; TETROFOSMIN TC 99M; RADIOPHARMACEUTICAL AGENT;

AGED; ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CT SPECT SCANNER; DATA BASE; FEASIBILITY STUDY; FEMALE; HEART MUSCLE PERFUSION; HUMAN; IMAGE RECONSTRUCTION; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL HIBERNATION; MYOCARDIAL PERFUSION IMAGING; PET-CT SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCAR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPECT SCANNER; ALGORITHM; ARTIFACT; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC USE; IMAGE ENHANCEMENT; MIDDLE AGED; MULTIMODAL IMAGING; PROCEDURES; REPRODUCIBILITY; RETROSPECTIVE STUDY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; STUNNED HEART MUSCLE;

AGED; ALGORITHMS; ARTIFACTS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MULTIMODAL IMAGING; MYOCARDIAL PERFUSION IMAGING; MYOCARDIAL STUNNING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84901679666     PISSN: 10713581     EISSN: 15326551     Source Type: Journal    
DOI: 10.1007/s12350-014-9882-8     Document Type: Article

References (23)

1. Camici PG, Prasad SK, Rimoldi OE. Stunning, hibernation, and assessment of myocardial viability. Circulation 2008;117:103-14. doi:10.1161/ CIRCULATIONAHA.107.702993. (Pubitemid 350301145)
2. Rischpler C, Nekolla S, Schwaiger M. PET and SPECT in heart failure. Curr Cardiol Rep 2013;15:337. doi:10.1007/s11886-012-0337-z.
3. Ghosh N, Rimoldi OE, Beanlands RSB, Camici PG. Assessment of myocardial ischaemia and viability: Role of positron emission tomography. Eur Heart J 2010;31:2984-95. doi:10.1093/eurheartj/ehq361.
4. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: A meta-analysis. J Am Coll Cardiol 2002;39:1151-8. (Pubitemid 34267418)
5. D'Egidio G, Nichol G, Williams KA, Guo A, Garrard L, deKemp R, et al. Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: A substudy of the PARR-2 trial. JACC Cardiovasc Imaging 2009;2:1060-8. doi:10.1016/j.jcmg.2009.02.017.
6. van Campen CMC, Visser FC, van der Weerdt AP, Knaapen P, Comans EF, Lammertsma AA, et al. FDG PET as a predictor of response to resynchronisation therapy in patients with ischaemic cardiomyopathy. Eur J Nucl Med Mol Imaging 2007;34:309-15. doi:10.1007/s00259-006-0235-y. (Pubitemid 46295353)
7. Nkoulou R, Pazhenkottil AP, Buechel RR, Husmann L, Valenta I, Herzog BA, et al. Impact of CT attenuation correction on the viability pattern assessed by 99mTc-tetrofosmin SPECT/18F-FDG PET. Int J Cardiovasc Imaging 2011;27:913-21. doi:10.1007/s10554-010-9719-8.
8. Parker MW, Iskandar A, Limone B, Perugini A, Kim H, Jones C, et al. Diagnostic accuracy of cardiac positron emission tomography versus single photon emission computed tomography for coronary artery disease: A bivariate meta-analysis. Circ Cardiovasc Imaging 2012;5:700-7. doi:10.1161/CIRCIMAGING. 112.978270.
9. Fricke E, Fricke H, Weise R, Kammeier A, Hagedorn R, Lotz N, et al. Attenuation correction of myocardial SPECT perfusion images with low-dose CT: Evaluation of the method by comparison with perfusion PET. J Nucl Med 2005;46:736-44.
10. Doukky R, Rahaby M, Alyousef T, Vashistha R, Chawla D, Amin AP, et al. Soft tissue attenuation patterns associated with supine acquisition spect myocardial perfusion imaging: A descriptive study. Open CardiovascMed J 2012;6:33-7. doi:10.2174/1874192401206010033.
11. Authors/Task Force Members, McMurray JJV, Adamopoulos S, Anker SD, Auricchio A, Böhm M, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012; doi:10.1093/eurheartj/ehs104.
12. Dilsizian V, Bacharach SL, Beanlands RS, Bergmann SR, Delbeke D, Gropler RJ, et al. PET myocardial perfusion and metabolism clinical imaging. J Nucl Cardiol 2009;16:651. doi:10.1007/s12350-009-9094-9.
13. Beanlands RSB, Ruddy TD, deKemp RA, Iwanochko RM, Coates G, Freeman M, et al. Positron emission tomography and recovery following revascularization (PARR-1): The importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function. J Am Coll Cardiol 2002;40:1735-43. (Pubitemid 35341950)
14. Slomka PJ, Nishina H, Berman DS, Akincioglu C, Abidov A, Friedman JD, et al. Automated quantification of myocardial perfusion SPECT using simplified normal limits. J Nucl Cardiol 2005;12:66-77.
15. Germano G, Kavanagh PB, Slomka PJ, Van Kriekinge SD, Pollard G, Berman DS. Quantitation in gated perfusion SPECT imaging: The Cedars-Sinai approach. J Nucl Cardiol 2007;14:433-54. doi:10.1016/j.nuclcard.2007.06.008. (Pubitemid 47163568)
16. Van Kriekinge SD, Nishina H, Ohba M, Berman DS, Germano G. Automatic global and regional phase analysis from gated myocardial perfusion SPECT imaging: Application to the characterization of ventricular contraction in patients with left bundle branch block. J Nucl Med 2008;49:1790-7. doi:10.2967/jnumed.108.055160.
17. Wenning C, Rahbar K, Vrachimis A, Schober O, Schäfers M, Stegger L. Myocardial perfusion imaging and coronary calcium scoring with a two-slice SPECT/CT system: Can the attenuation map be calculated from the calcium scoring CT scan? Eur J Nucl Med Mol Imaging 2013. doi:10.1007/s00259-013-2360-8.
18. Okuda K, Nakajima K, Matsuo S, Wakabayashi H, Taki J, Kinuya S, et al. Cause of apical thinning on attenuation-corrected myocardial perfusion SPECT. Nucl Med Commun 2011;32:1033-9. doi:10.1097/MNM.0b013e32834b69e1.
19. Links JM, Becker LC, Anstett F. Clinical significance of apical thinning after attenuation correction. J Nucl Cardiol 2004;11:26-31. doi:10.1016/j. nuclcard.2003.10.004. (Pubitemid 38219566)
20. Hendel RC. Attenuation correction: Eternal dilemma or real improvement? Q J Nucl Med Mol Imaging. 2005;49:30-42. (Pubitemid 41557523)
21. Duvall WL, Slomka PJ, Gerlach JR, Sweeny JM, Baber U, Croft LB, et al. High-efficiency SPECT MPI: Comparison of automated quantification, visual interpretation, and coronary angiography. J Nucl Cardiol 2013;20:763-73. doi:10.1007/s12350-013-9735-x.
22. Goetze S, Brown TL, Lavely WC, Zhang Z, Bengel FM. Attenuation correction in myocardial perfusion SPECT/CT: Effects of misregistration and value of reregistration. J Nucl Med 2007;48:1090-5. doi:10.2967/jnumed.107.040535. (Pubitemid 47052647)
23. Lautamäki R, Brown TLY, Merrill J, Bengel FM. CT-based attenuation correction in (82)Rb-myocardial perfusion PET-CT: Incidence of misalignment and effect on regional tracer distribution. Eur J Nucl Med Mol Imaging 2008;35:305-10. doi: 10.1007/s00259-007-0607-y.